| D008168 |
Lung |
Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. |
Lungs |
|
| D011663 |
Pulmonary Surfactants |
Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. |
Surfactants, Pulmonary,Pulmonary Surfactant,Surfactant, Pulmonary |
|
| D002454 |
Cell Differentiation |
Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. |
Differentiation, Cell,Cell Differentiations,Differentiations, Cell |
|
| D005314 |
Embryonic and Fetal Development |
Morphological and physiological development of EMBRYOS or FETUSES. |
Embryo and Fetal Development,Prenatal Programming,Programming, Prenatal |
|
| D006003 |
Glycogen |
|
|
|
| D006728 |
Hormones |
Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. |
Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000818 |
Animals |
Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. |
Animal,Metazoa,Animalia |
|
| D050356 |
Lipid Metabolism |
Physiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS. |
Metabolism, Lipid |
|